title: Interpretation of the tuberculin skin test in bacille Calmette-Guérin vaccinated and nonvaccinated school children.
abstract: BACKGROUND
  Our objective was to conduct a prevalence survey of purified protein derivative (PPD) reactions among Lebanese healthy school children to identify those with tuberculosis or latent tuberculosis and to investigate the effect of bacille Calmette-Guérin (BCG) vaccine on the interpretation of PPD reactivity.
  
  
  METHODS
  A self-administered questionnaire, including demographic characteristics, time of prior BCG vaccine and number of doses, known household contact with tuberculosis as well as parents' characteristics and living conditions was administered. PPD testing was performed on all children in diverse Lebanese regions aged 3 to 19 years. Reactivity that measured <5 mm were considered negative induration, doubtful if between 5 and 9 mm and positive if 10 mm or above. Chest radiographs were obtained as part of the evaluation for children with positive induration.
  
  
  RESULTS
  Of 4895 children, 4271 entered into the final data analysis. A total of 3259 children (76.3%) did not develop a reaction to PPD (0 mm), 170 (4%) had 1 to <5 mm reading, 509 (11.9%) had 5 to 9 mm and 333 (7.8%) had > or =10 mm. Approximately 62% of the vaccinated children had received BCG vaccine in first year of life. Two hundred ninety (61.8%) of 469 children < or =5 were vaccinated and 179 (38.2%) were not. Only 22 of the youngest vaccinated had positive PPD. Twelve children were diagnosed with tuberculosis, a prevalence of 280 per 100,000. However, the prevalence of latent tuberculosis was 7.51%.
  
  
  CONCLUSIONS
  Our prevalence of tuberculosis and latent tuberculosis is a sentinel indicator of continued transmission in the community. The data support the current recommendations that children who receive BCG can and should be tested with PPD for latent tuberculosis and tuberculosis.
authors.affiliation: Pediatric Department, International Medical Center, Jeddah, KSA.
authors.forename: Rola
authors.initials: R
authors.lastname: Sleiman
authors.forename: Mohamad
authors.initials: M
authors.lastname: Al-Tannir
authors.forename: Ghenwa
authors.initials: G
authors.lastname: Dakdouki
authors.forename: Fouad
authors.initials: F
authors.lastname: Ziade
authors.forename: Nahla Abou
authors.initials: NA
authors.lastname: Assi
authors.forename: Mariam
authors.initials: M
authors.lastname: Rajab
mesh_terms: D001500:BCG Vaccine / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007861:Lebanon; D008168:Lung / Q000000981:diagnostic imaging; D008297:Male; D015995:Prevalence; D011859:Radiography; D011795:Surveys and Questionnaires; D014373:Tuberculin / Q000276:immunology*; D014374:Tuberculin Test; D014376:Tuberculosis / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology*
chemical_list: D001500:BCG Vaccine; D014373:Tuberculin